Overview
Brainsway worked with Antenna Group to increase awareness of clinical depression and its Deep TMS solution among physicians and patients.
Situation
- Brainsway developed Deep Transcranial Magnetic Stimulation (Deep TMS), a unique technology used to treat clinical depression and other mental disorders.
- Brainsway charged Antenna Group with increasing awareness of clinical depression and Deep TMS among physicians and patients.
Approach
- Antenna Group worked with Brainsway providers in various regions around the world to position them as experts and thought leaders in clinical depression.
- Partnered with leading physicians from institutions including Harvard Medical School and Mount Sinai to fine-tune their messaging and identify patients who would share their story with the media.
Results
- Antenna Group reached 150M+ people through media placements that targeted physicians, consumers, and investors.
- Successfully raised Brainsway’s U.S. profile, driving a boost in partnerships with leading institutions and key physicians, as well as increased patient awareness.
About
BrainsWay is an Israeli company with international operations that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a noninvasive treatment for depression. The company was founded in 2003 and has offices in the US and Jerusalem, Israel.
Visit Website